DHG Pharmaceutical JSC (HOSE: DHG)
Vietnam
· Delayed Price · Currency is VND 101,500
-1,800 (-1.74%)
At close: Jan 21, 2025
DHG Pharmaceutical JSC Cash Flow Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 778,920 | 778,920 | 1,050,663 | 988,455 | 777,220 | 739,875 | Upgrade
|
| Depreciation & Amortization | 169,695 | 169,695 | 87,720 | 81,001 | 82,564 | 88,197 | Upgrade
|
| Other Amortization | - | - | 984.1 | - | 1,299 | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -139,127 | -139,127 | -203,609 | -112,319 | -106,218 | -136,185 | Upgrade
|
| Other Operating Activities | -9,538 | -9,538 | -11,828 | -56,715 | -43,544 | -18,164 | Upgrade
|
| Change in Accounts Receivable | 105,103 | 105,103 | -268,589 | 34,206 | 22,427 | 69,743 | Upgrade
|
| Change in Inventory | 420,960 | 420,960 | -286,890 | -177,950 | -246,313 | -101,120 | Upgrade
|
| Change in Accounts Payable | -21,510 | -21,510 | -129,051 | 160,321 | -33,242 | 171,398 | Upgrade
|
| Change in Other Net Operating Assets | 13,080 | 13,080 | 772.15 | -15,714 | -1,749 | 12,430 | Upgrade
|
| Operating Cash Flow | 1,317,583 | 1,317,583 | 240,171 | 901,285 | 452,444 | 826,174 | Upgrade
|
| Operating Cash Flow Growth | 448.60% | 448.60% | -73.35% | 99.20% | -45.24% | -1.44% | Upgrade
|
| Capital Expenditures | -88,705 | -88,705 | -486,343 | -233,992 | -24,562 | -88,805 | Upgrade
|
| Sale of Property, Plant & Equipment | 967.73 | 967.73 | 1,654 | 3,334 | 4,632 | 5,238 | Upgrade
|
| Investment in Securities | - | - | - | 3,206 | 84.72 | 8,629 | Upgrade
|
| Other Investing Activities | 156,786 | 156,786 | 179,869 | 118,723 | 101,430 | 132,792 | Upgrade
|
| Investing Cash Flow | -445,951 | -445,951 | -179,819 | -353,729 | 45,694 | -248,092 | Upgrade
|
| Short-Term Debt Issued | 1,708,085 | 1,708,085 | 1,524,390 | 737,941 | 794,683 | 736,698 | Upgrade
|
| Total Debt Issued | 1,708,085 | 1,708,085 | 1,524,390 | 737,941 | 794,683 | 736,698 | Upgrade
|
| Short-Term Debt Repaid | -1,630,335 | -1,630,335 | -1,066,949 | -830,609 | -799,564 | -789,094 | Upgrade
|
| Total Debt Repaid | -1,630,335 | -1,630,335 | -1,066,949 | -830,609 | -799,564 | -789,094 | Upgrade
|
| Net Debt Issued (Repaid) | 77,749 | 77,749 | 457,441 | -92,668 | -4,880 | -52,395 | Upgrade
|
| Common Dividends Paid | -980,596 | -980,596 | -457,611 | -457,611 | -522,984 | -522,984 | Upgrade
|
| Financing Cash Flow | -902,846 | -902,846 | -170.11 | -550,279 | -527,865 | -575,380 | Upgrade
|
| Foreign Exchange Rate Adjustments | -62.53 | -62.53 | -65.74 | -222.19 | 45.25 | 23.7 | Upgrade
|
| Net Cash Flow | -31,276 | -31,276 | 60,116 | -2,946 | -29,681 | 2,726 | Upgrade
|
| Free Cash Flow | 1,228,879 | 1,228,879 | -246,171 | 667,293 | 427,882 | 737,369 | Upgrade
|
| Free Cash Flow Growth | - | - | - | 55.95% | -41.97% | -5.60% | Upgrade
|
| Free Cash Flow Margin | 25.16% | 25.16% | -4.91% | 14.27% | 10.69% | 19.63% | Upgrade
|
| Free Cash Flow Per Share | 9398.97 | 9398.97 | -1882.82 | 5103.73 | 3272.62 | 5639.70 | Upgrade
|
| Cash Interest Paid | - | - | 29,299 | 12,558 | 12,050 | 14,279 | Upgrade
|
| Cash Income Tax Paid | - | - | 104,854 | 100,999 | 99,613 | 78,841 | Upgrade
|
| Levered Free Cash Flow | 1,955,870 | 1,955,870 | -506,459 | 447,363 | 260,730 | 662,163 | Upgrade
|
| Unlevered Free Cash Flow | 1,971,377 | 1,971,377 | -488,003 | 455,212 | 268,280 | 670,932 | Upgrade
|
| Change in Net Working Capital | -1,315,214 | -1,315,214 | 748,040 | 64,346 | 329,011 | -165,780 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.